The decrease in CarnoSyn ® beta-alanine royalty, licensing, and raw material sales revenue during the second quarter of fiscal 2025 was primarily due to a decrease in orders from existing customers.
Starlight U.S. Residential Fund (TSXV: SURF.A) (TSXV: SURF.U) (the "Fund") announced today its results of operations and financial condition for the three months ended December 31, 2024 ("Q4-2024") ...
Shares of Redington reached a new record high on February 14, following news about divestment from its subsidiary Arena ...
HD's growth remains strong. But high rates and weak big-ticket demand pose challenges. Is it a buy or hold? Investors should ...
One such token is the Hyperliquid layer-1 blockchain’s HYPE token, which has outperformed the cryptocurrency market since its ...
Newsable Asianet News on MSN23h
Will Meta Stock’s Dream 19-Session Run Snap? Retail Bearish Even As Social Media Giant Hikes DividendMeta Plaforms, Inc. (META) stock has been on a 19-session winning streak and it is among the best-performing S&P 500 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback